Torin2, a potent novel dual mTOR complex inhibitor reduced growth of TFE3-fusion RCC cell lines in 2D and 3D models at low nanomolar concentrations (Supplementary Figure S2). This evidence concerns the gene MTOR and renal cell carcinoma.